"Nouv Rev Fr Hematol"

Key Phrases: Clin Invest, Biol Chem, Proc Natl Acad Sci, Thromb Haemost, Clin Oncol, Ann Intern Med, allogeneic hematopoietic cell transplantation, essential monoclonal gammopathy, oligoblastic leukemia, patients with idiopathic myelofibrosis, clonal myeloid diseases, hematopoietic stem cell diseases (see more)

Key Phrases: Clin Invest, Biol Chem, Proc Natl Acad Sci, Thromb Haemost, Clin Oncol, Ann Intern Med, Exp Med, Clin Pathol, New York, Lab Clin Med, Arch Intern Med, United States, Acta Haematol, Semin Hematol, Exp Hematol, Obstet Gynecol, Cancer Res, Med Sci, Thromb Res, Hum Genet, Vox Sang, Cancer Genet Cytogenet, Biochim Biophys Acta, Dis Child, Leuk Res, allogeneic hematopoietic cell transplantation, essential monoclonal gammopathy, oligoblastic leukemia, patients with idiopathic myelofibrosis, clonal myeloid diseases, hematopoietic stem cell diseases, lymphohematopoietic stem cells, nonhemophilic patients, oligoblastic myelogenous, uremic hemolytic syndrome, acute megaloblastic anemia, hematopoietic cell production, macroglobulinemia patients, prolonged continuation therapy, serum prothrombin time, hereditary nonspherocytic hemolytic anemia, adventitial reticular cells, apheresis platelet concentrates, heavy chain disease protein, platelet kinetic studies, platelet coagulant activity, clonal myeloid disorders, direct antiglobulin test result, human preleukemia, red cell injury (see less)

Key Phrases: Clin Oncol, Ann Intern Med, Cancer Res, Clin Pathol, Bence Jones, Leuk Lymphoma, myeloma cell proliferation, percent plasma cells, myeloma cell growth, clonal plasma cells, percent complete response rate, plasma cell labeling index (see more)

Key Phrases: Clin Oncol, Ann Intern Med, Cancer Res, Clin Pathol, Bence Jones, Leuk Lymphoma, Proc Natl Acad Sci, United States, New York, Natl Cancer Inst, Ann Oncol, Clin Invest, Semin Oncol, Exp Med, Semin Hematol, Leuk Res, Arch Intern Med, Cancer Genet Cytogenet, Pediatric Oncology Group, Med Pediatr Oncol, National Cancer Institute, Exp Hematol, Surg Pathol, Acta Haematol, Eastern Cooperative Oncology Group, myeloma cell proliferation, percent plasma cells, myeloma cell growth, clonal plasma cells, percent complete response rate, plasma cell labeling index, gamma heavy chain disease, deleted heavy chains, peripheral blood plasma cells, acute terminal phase, leukemic cell population, plasma cell neoplasia, alpha chain disease, circulating plasma cells, heavy chain disease protein, plasma cell morphology, marrow plasma cells, dendritic cell tumors, meningeal myelomatosis, multiple nryeloma, serum syndecan, granulocyte transfusion therapy, immunoproliferative small intestinal disease, blood processor, noncleaved cell lymphoma (see less)

Key Phrases: Clin Oncol, Leuk Lymphoma, Exp Med, Clin Pathol, French Cooperative Group, Cancer Res, patients receiving fludarabine, cold agglutination syndrome, significant association between survival, gene mutational status, cyclophosphamide combination regimen, immune costimulatory molecules (see more)

Key Phrases: Clin Oncol, Leuk Lymphoma, Exp Med, Clin Pathol, French Cooperative Group, Cancer Res, Leuk Res, Semin Oncol, Proc Natl Acad Sci, Historical Perspective, New York, Clin Invest, Cancer Genet Cytogenet, Humana Press Inc, Management Edited, Ann Intern Med, Bone Marrow Transplant, Natl Cancer Inst, Nouv Rev Fr Hematol, Marcel Dekker, National Cancer Institute, Semin Hematol, Immunol Today, International Workshop, Gene Ther, patients receiving fludarabine, cold agglutination syndrome, significant association between survival, gene mutational status, cyclophosphamide combination regimen, immune costimulatory molecules, chronic lymphocytic leukemia cells, familial chronic lymphocytic leukemia, weekly rituximab, lymphocytic leukaemia cells, untreated chronic lymphocytic leukemia, median survival probability, unmutated antigen receptors, purine analog therapy, receiving fludarabine regimens, gene mutation status, chronic lymphocytic leukemia patients, fludarabine therapy, lymphocyte doubling time, atypical lymphocyte morphology, cell chronic lymphocytic leukemia, chronic lymphocytic leukemia derived, genomic aberrations, accumulative disease, fludarabine treatment (see less)

Key Phrases: Clin Oncol, Leuk Lymphoma, Cancer Res, Exp Med, Proc Natl Acad Sci, Clin Pathol, cold agglutination syndrome, unmutated group, untreated chronic lymphocytic leukemia, chronic lymphocytic leukemia resistant, chronic lymphocytic leukemia cells, prior fludarabine (see more)

Key Phrases: Clin Oncol, Leuk Lymphoma, Cancer Res, Exp Med, Proc Natl Acad Sci, Clin Pathol, Semin Oncol, National Cancer Institute, New York, Ann Intern Med, Leuk Res, Semin Hematol, United States, Clin Invest, Ann Oncol, Cancer Genet Cytogenet, Ind Med, Biol Chem, Natl Cancer Inst, Eastern Cooperative Oncology Group, Anderson Cancer Center, Clin Exp Immunol, Immunol Today, Nouv Rev Fr Hematol, International Workshop, cold agglutination syndrome, unmutated group, untreated chronic lymphocytic leukemia, chronic lymphocytic leukemia resistant, chronic lymphocytic leukemia cells, prior fludarabine, gene mutation status, advanced chronic lymphocytic leukemia, lymphocytic leukaemia cells, chlorambucil for patients, early chronic lymphocytic leukemia, surface membrane phenotype, fludarabine therapy, alkylator regimens, nucleoside analog therapy, receiving fludarabine regimens, unmutated cases, peripheral blood morphology, thrice weekly rituximab, lymphocyte doubling time, clonal relatedness, chronic lymphocytic leukemia patients, refractory chronic lymphocytic leukemia, familial chronic lymphocytic leukemia, cell chronic lymphocytic leukemia (see less)